Your session is about to expire
← Back to Search
Laser Treatment for Glaucoma Prevention in Corneal Disease
Study Summary
This trial is studying whether a laser treatment can help prevent glaucoma in patients receiving a Boston keratoprosthesis, a device used to restore vision in patients who have failed traditional corneal transplants.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I can attend all required study visits.I have ocular albinism.I have a tumor inside my eye.I am an adult.I am unable to understand and agree to the study's details on my own.I had glaucoma surgery or a procedure for it within the last 3 months.I have a severe eye surface condition with hardening.I have been diagnosed with advanced stage glaucoma.I am 18 years old or older.I have a shrunken or non-functional eye.I am between 18 and 80 years old.I can attend all required study visits.
- Group 1: Historical Cohort
- Group 2: G-Probe Treatment
- Group 3: MicroPulse Treatment
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What criteria must an individual meet in order to be eligible for participation in this research endeavor?
"This clinical trial is currently open to a cohort of 20 adults, aged 18 to 80, who are afflicted with some form of eye illness. In addition, participants must be capable of being monitored throughout the course of this study."
Is this study welcoming participants aged 45 or older?
"This study seeks participants that are of legal age or above and have not yet reached the age of octogenarianism."
How many individuals have signed up to participate in this experiment?
"Affirmative, the trial listed on clinicaltrials.gov is actively seeking participants for enrollment. Originally posted in January 30th 2020 and updated as recently as March 14th 2022, this study requires 20 individuals from a single site to join its ranks."
Is enrollment open for this medical experiment?
"According to info sourced from clinicaltrials.gov, this study is actively attempting to complete recruitment. It was first posted on January 30th 2020 and last modified on March 14th 2022."
Who else is applying?
How old are they?
What portion of applicants met pre-screening criteria?
What state do they live in?
Share this study with friends
Copy Link
Messenger